Home › Grants › United States › Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressi
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions.
Grant (non-repayable) Open now
- Funder
- Food and Drug Administration
Funder profile and all of its programs - Amount
- Up to $900,000 per award (published on Grants.gov).
- Where
- United States (federal)
- Eligibility
- Eligible applicant types are set out on the official page. No cost sharing is required.
- Sectors
- Agriculture and agri-food, Health and life sciences, Research and science
- Deadline
- Closes 16 May 2028
- Source
- Grants.gov XML extract (RFA-FD-25-020)
- Last checked
- 2 November 2026
- Funder contacts
- Public organizational contacts on file Unlock full profile / Sign up
From official open data: listed in the official Grants.gov extract on 2026-11-02. The summary is from the official listing; the eligibility line is our plain-language reading of its eligibility codes. Confirm details on the official page.
Related grant lists
Agriculture and agri-food Health and life sciences Research and science Nonprofits and charities United States United States (national) Federal agency $500,000 to $1 million May 2028
Full eligibility results and funder contacts come with Pro and Lifetime, coming soon.
Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.